WAVE Life Sciences Ltd. | Ownership
Companies that own WAVE Life Sciences Ltd.
RA Capital Management LLC
7,512,049
25.62%
0
22.09%
06/30/2018
Redmile Group LLC
2,244,507
7.66%
6,900
3.7%
06/30/2018
T. Rowe Price Associates, Inc.
1,661,851
5.67%
-76,234
0.01%
06/30/2018
Tavistock Life Sciences Co. (Investment Management)
1,590,600
5.43%
240,600
5.81%
06/30/2018
Henderson Global Investors Ltd.
1,518,758
5.18%
160,545
0.04%
06/30/2018
Bellevue Asset Management AG
1,137,885
3.88%
241,789
0.88%
06/30/2018
BlackRock Fund Advisors
1,112,892
3.8%
289,990
0%
06/30/2018
Fidelity Management & Research Co.
1,036,878
3.54%
59,879
0.01%
06/30/2018
Bridger Management LLC
562,615
1.92%
43,180
1.43%
06/30/2018
ArrowMark Colorado Holdings LLC
454,999
1.55%
66,280
0.22%
06/30/2018
| Address |
Marina One East Tower
Singapore CE 018936
Singapore
|
|
Employees
|
- |
| Website |
http://www.wavelifesciences.com |
| Updated |
07/08/2019 |
| Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. |
